A persistent rise in mortality among injection drug users in Rome, 1980 through 1992

American Journal of Public Health

Volumn 87, Issue 5, 1997, Pages 851-853

  Davoli, Marina ^a   Perucci, Carlo A ^a,b   Rapiti, Elisabetta ^a   Bargagli, Anna Maria ^a   D'Ippoliti, Daniela ^a   Forastiere, Francesco ^a   Abeni, Damiano ^a  

^a Department of Epidemiology ^*  (Italy)

^b Osservatorio Epidemiologico Reglone Lazio   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DRUG USE; FEMALE; HUMAN; INJECTION; INTOXICATION; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY;

EID: 0030975827     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.87.5.851     Document Type: Article

References (13)

1. Selwyn PA. Injection drug use, mortality, and the AIDS epidemic. Am J Public Health. 1991;81:1247-1249.
2. Perucci CA, Davoli M, Rapiti E, Abeni D, Forastiere F. Mortality of intravenous drug users in Rome: a cohort study. Am J Public Health. 1991;81:1307-1310.
3. Stoneburner RL, Des Jarlais DC, Benezra D, et al. A larger spectrum of severe HIV-1 related disease in intravenous drug users in New York City. Science. 1988;242:916-919.
4. Verdecchia A, Mariotto A, Capocaccia R, Mariotti S. An age and period reconstruction of the HIV epidemic in Italy. Int J Epidemiol. 1994;23:1027-1039.
5. Arcá M, Perucci CA, Spadea T. The epidemic dynamics of HIV-1 in Italy: modelling the interaction between intravenous drug users and heterosexual population. Stat Med. 1992;11:1657-1684.
6. Brancato G, Rapiti E, Abeni D, et al., for the Italian Seroconversion Study and Multicenter Prospective HIV Study. Multiple imputation technique in estimating incidence of HIV infection. In: Proceedings of XI International Conference on AIDS. Vancouver, July 7-12, 1996.
7. Cox DR, Oakes D. Analysis of Survival Data. Monographs on Statistics and Applied Probability. London, England: Chapman & Hall; 1984:48-61.
8. Galli M, Musicco M, for the COMCAT Study Group. Mortality of intravenous drug users living in Milan, Italy: role of HIV-1 infection. AIDS. 1994;8:1457-1463.
9. Rezza G, Salmaso S, Abeni D, et al. HIV prevalence and frequency of risk behaviour in injecting drug users entering-treatment and out-of-treatment: across-sectional study in five Italian cities. J Drug Issues. 1994;24:527-535.
10. Caiaffa WT, Vlahov D, Graham NM, et al. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am J Respir Crit Care Med. 1994;150:1493-1498.
11. Davoli M, Perucci CA, Abeni DD, et al. HIV risk-related behaviors among injection drug users in Rome: differences between 1990 and 1992. Am J Public Health. 1995;85:829-832.
12. Multi-City Study on Drug Injecting and Risk of HIV Infection, Geneva, Switzerland: World Health Organization, Programme on Substance Abuse; 1994. Report prepared on behalf of the WHO International Collaborative group.
13. Alcabes P, Munoz A, Vlahov D, Friedland GH. Incubation period of human immunodeficiency virus. Epidemiol Rev. 1993;15: 303-318.